As AI's infrastructure sparks community resistance, its creators are also planning a more intimate push into our daily lives, targeting the family unit.

AI accelerates pharmaceutical research by 87%, while robotics and healthcare see major advances, even as the industry's financial scale and ethical challenges come into sharper focus.

From billion-dollar chip deals to AI-powered consumer scams, the industry accelerates on all fronts. Today's news highlights runaway startup growth, critical hardware supply chains, and the messy reality of deploying AI at scale.

AI agents move from laptops to our pockets and warzones, while the tech industry grapples with the workforce impacts and ethical dilemmas these powerful tools create.

Microsoft's latest layoffs spark fears of AI-driven displacement, even as new accelerators launch in Europe and elite AI-powered schools emerge. Meanwhile, China sets rules for AI companions, and Amazon winds down a key data-labeling platform.

Google's AI ad sparks mockery, Midjourney fights Hollywood, and the fanfiction community grapples with AI detection tools, highlighting growing cultural tensions.

Today's news spans a major pharma AI deal, a Hollywood research pact, Anthropic's scientific pivot, and fresh scrutiny of Midjourney's medical hardware.

Major AI labs pivot towards science and entertainment, a $600M pharma deal signals industry confidence, and the line between AI hype and reality gets blurrier.

Microsoft doubles down on AI deployment, OpenAI floats a controversial government stake, and Venice AI hits unicorn status as the industry's infrastructure and political battles intensify.

Venice AI hits a $1B+ valuation on a privacy-first promise, while Google and Anthropic push agents onto desktops and into workflows. Meanwhile, new research warns of fundamental AI vulnerabilities.